🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ANDROMEDA study - DARA+CYBORD in new diagnosis AL #amyloidosis : ORR - hematologic 96% , VGPR or better was 82%; 10 (36%) patients achieved CR. Median time to first response was 23 days, and median time to CR and VGPR were 85 (29-226) and 22 (7-228) days. #EHA24 #EHA2019

Treatment with ixazomib did not demonstrate a significant improvement in overall hematologic response compared to physician’s choice of standard of care regimens in r/r primary amyloidosis. #amyloidosis takeda.com/newsroom/newsr…

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure | Scientific Reports #amyloidosis #mmsm #myeloma #cardiology #hemonc nature.com/articles/s4159…